News
Discover the potential consequences of mRNA vaccine development cuts on poultry health and infectious disease management in ...
NewsNation on MSN2h
NIH head: mRNA vaccine cuts made because public doesn’t trust them
( NewsNation) — National Institutes of Health director Jay Bhattacharya believes mRNA vaccine technology is “promising” but ...
Opinion
2hon MSNOpinion
Maddow Blog | Trump’s NIH chief tries (and fails) to defend cuts to mRNA vaccine research
The NIH's Jay Bhattacharya tried his best pitch to explain the Trump administration's shift away from mRNA vaccine research. His case fell far short.
The company is not developing an mRNA vaccine, but had been using one as the control in a 10,000-subject Phase IIb trial.
In a new episode of the video series STATus Report, a closer look at the reasons health secretary RFK Jr. cited for canceling contracts on mRNA vaccine research.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback